Cargando…
TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
Autores principales: | Szenes, Eva, Härzschel, Andrea, Decker, Sarah, Tissino, Erika, Pischeli, Justine, Gutjahr, Julia Christine, Kissel, Sandra, Pennisi, Sandra, Höpner, Jan Philip, Egle, Alexander, Zaborsky, Nadja, Dierks, Christine, Follo, Marie, Chigaev, Alexandre, Zucchetto, Antonella, Greil, Richard, Gattei, Valter, Hartmann, Tanja Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449868/ https://www.ncbi.nlm.nih.gov/pubmed/32086446 http://dx.doi.org/10.1038/s41375-020-0759-3 |
Ejemplares similares
-
AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL
por: Schubert, Maria, et al.
Publicado: (2021) -
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development
por: Zaborsky, Nadja, et al.
Publicado: (2018) -
An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy
por: Cohen, Jared A., et al.
Publicado: (2020) -
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia
por: Parigger, Thomas, et al.
Publicado: (2021) -
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
por: Gutjahr, Julia C., et al.
Publicado: (2020)